PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34935149-0	2022	Colony-stimulating factor-1 receptor inhibition attenuates microgliosis and myelin loss but exacerbates neurodegeneration in the chronic cuprizone model.	Cuprizone	137-146	colony stimulating factor 1 receptor	Mus musculus	0-36	
34935149-6	2022	Therefore, our goal was to evaluate the effects of a reduction in microglial activation through orally administered brain-penetrant colony-stimulating factor-1 receptor (CSF-1R) inhibitor BLZ945 (BLZ) on neurodegeneration and its correlation with demyelination, astroglial activation and behavior in a chronic CPZ-induced demyelination model.	Cuprizone	310-313	colony stimulating factor 1 receptor	Mus musculus	132-168	
34935149-6	2022	Therefore, our goal was to evaluate the effects of a reduction in microglial activation through orally administered brain-penetrant colony-stimulating factor-1 receptor (CSF-1R) inhibitor BLZ945 (BLZ) on neurodegeneration and its correlation with demyelination, astroglial activation and behavior in a chronic CPZ-induced demyelination model.	Cuprizone	310-313	colony stimulating factor 1 receptor	Mus musculus	170-176	
34274854-0	2021	Effect of CSF1R inhibitor on glial cells population and remyelination in the cuprizone model.	Cuprizone	77-86	colony stimulating factor 1 receptor	Mus musculus	10-15	
32082318-5	2020	We found that after 5 weeks of cuprizone diet that CSF1R suppression caused a significant impairment of microglia function.	Cuprizone	31-40	colony stimulating factor 1 receptor	Mus musculus	51-56	
29448957-11	2018	Taken together, our data suggest that a short-term therapeutic inhibition of the CSF-1 receptor pathway by BLZ945 in the murine cuprizone model enhances central remyelination by modulating neuroinflammation.	Cuprizone	128-137	colony stimulating factor 1 receptor	Mus musculus	81-95